Mirtazapine-d3, 10mg

2-Dicyclohexylphosphino-2'-methylbiphenyl>97.0%(GC)1g

Ethyl 4-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 98%, 250mg

(S)-4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid compound with benzenesulfonic acid (1:1), 98%, 5g

(2-Boc-Aminophenyl)boronic acid, 95.0%, 1g

Sodium (S)-6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide, 95.0%, 1g

(3R,4R,5R)-6-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexane-1,2,3,4,5-pentaol, 97.0%, 250mg

(R)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-2-METHYLHEPT-6-YNOIC ACID, 95%, 1g

trans,trans-4-Butyl-4'-(3,4,5-trifluorophenyl)-1,1'-bi(cyclohexyl)>98.0%(GC)1g

Pentanethioamide, 95%, 500mg

Ethanone, 1-[1-[2-(methylsulfonyl)phenyl]-7-propoxy-3-indolizinyl]-, 5mg

bScope BS.1152-PLPHi per contrasto di fase. Bioculare con oculari HWF 10x/20 mm e revolver Fivefold E-plan Phase IOS 10/20/S40 S100x

D-Lactic Acid>90.0%(T)5g